Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.191
+0.004 (2.04%)
Dec 26, 2024, 11:29 AM EST - Market open
Vincerx Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 12.24 | 13.64 | 18.89 | 22.58 | 3.6 | 0.05 |
| Research & Development | 15.93 | 28.97 | 49.84 | 40.08 | 2.12 | - |
| Operating Expenses | 28.17 | 42.61 | 68.72 | 62.66 | 5.71 | 0.05 |
| Operating Income | -28.17 | -42.61 | -68.72 | -62.66 | -5.71 | -0.05 |
| Interest & Investment Income | 0.61 | 1.25 | 0.66 | - | - | - |
| Other Non Operating Income (Expenses) | 0.53 | 1.2 | 7.54 | 23.35 | -5.91 | - |
| EBT Excluding Unusual Items | -27.03 | -40.16 | -60.52 | -39.31 | -11.62 | -0.05 |
| Merger & Restructuring Charges | - | - | -2.47 | - | - | - |
| Pretax Income | -27.03 | -40.16 | -62.98 | -39.31 | -16.62 | -0.05 |
| Net Income | -27.03 | -40.16 | -62.98 | -39.31 | -16.62 | -0.05 |
| Net Income to Common | -27.03 | -40.16 | -62.98 | -39.31 | -16.62 | -0.05 |
| Shares Outstanding (Basic) | 31 | 21 | 21 | 17 | 5 | 4 |
| Shares Outstanding (Diluted) | 31 | 21 | 21 | 17 | 5 | 4 |
| Shares Change (YoY) | 47.84% | 1.26% | 22.43% | 227.04% | 17.65% | - |
| EPS (Basic) | -0.86 | -1.89 | -3.00 | -2.29 | -3.16 | -0.01 |
| EPS (Diluted) | -0.86 | -1.89 | -3.00 | -2.29 | -3.16 | -0.01 |
| Free Cash Flow | -27.97 | -40.45 | -59.6 | -33.66 | -2.28 | - |
| Free Cash Flow Per Share | -0.89 | -1.90 | -2.83 | -1.96 | -0.43 | - |
| EBITDA | -28.12 | -42.56 | -68.67 | -62.63 | - | - |
| D&A For EBITDA | 0.05 | 0.05 | 0.05 | 0.03 | - | - |
| EBIT | -28.17 | -42.61 | -68.72 | -62.66 | -5.71 | -0.05 |
Source: S&P Capital IQ. Standard template.
Financial Sources.